Search

everythinglearnresearchcommunity

for

Search:↓

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

TNF-alpha inhibitors can cause various immune-related skin issues.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

A medication for skin rash also unexpectedly treated hair loss in a patient.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

The document summarizes important skin care topics for non-specialist doctors, including treatments for skin conditions and the management of skin diseases.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Hidradenitis suppurativa might be a type of autoinflammatory skin disease.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Personalized care and evidence-based treatments are crucial for managing skin and hair conditions.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

The woman was diagnosed with lichen sclerosus, a rare skin condition, after initial misdiagnosis and ineffective treatments.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

The congress highlighted concerns about the effectiveness of over-the-counter nail treatments, the link between hair loss and daily care products, and the safety of skin treatments during COVID-19.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Turkish pregnant women commonly experienced skin issues like itching and acne, and doctors mainly used topical treatments due to safety concerns during pregnancy.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Immune cells affect hair growth and could lead to new hair loss treatments.